AU Stock MarketDetailed Quotes
PAR Paradigm Biopharmaceuticals Ltd
- 0.270
- -0.015-5.26%
20min DelayTrading Jul 25 13:02 AET
94.60MMarket Cap-1508P/E (Static)
0.290High0.265Low671.97KVolume0.290Open0.285Pre Close186.46KTurnover0.94552wk High0.22%Turnover Ratio350.36MShares0.21052wk Low-0.233EPS TTM84.46MFloat Cap4.500Historical HighLossP/E (Static)312.80MShs Float0.210Historical Low-0.179EPS LYR8.77%Amplitude--Dividend TTM2.78P/B1Lot Size--Div YieldTTM
About Paradigm Biopharmaceuticals Ltd Company
Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).
Company Profile
SymbolPAR
Company NameParadigm Biopharmaceuticals Ltd
Founded2014
MarketASX
Employees50
Fiscal Year Ends06-30
Address500 Collins Street Level 15
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 396295566
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
Company Executives
- Name
- Position
- Salary
- Dr. Donna Skerrett
- Director and Chief Medical Officer
- --
- Paul Rennie
- Executive Chairman of the Board and Managing Director
- --
- Helen Fisher, B.Sc. ,L.L.B.,L.L.M.
- Director
- --
- John Gaffney
- Director
- --
- Amos Meltzer
- Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg